MedPath

The exploratory study for the biological effects of metformin on endometrial cancer: effect to cell cycle, MAPK, and AMPK/mTOR signal pathway

Not Applicable
Recruiting
Conditions
endometrial carcinoma
Registration Number
JPRN-UMIN000004852
Lead Sponsor
Graduate School of Medicine, Chiba University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

(1) The case with a history of the hypersensitivity that is serious for this study use medicine or the drug allergy (2)A history of the lactic acidosis (3)Patients on dialysis (4)Shock, failure heart, myocardial infarction, a cardiovascular injury including the pulmonary embolism (5)Excessive alcohol intake (6)Hepatic dysfunction (7) A history of the thrombosis (8)A case with the psychic disturbance that it seems that we need in the treatment or treatment with antimental medicine (9) Patients with diabetes (10)A case with the double cancer of the activity (11)In addition, the case that the chief physician judged to be inadequate.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath